Found: 7
Select item for more details and to access through your institution.
The Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis Offers Efficient Bystander Cell Killing for Suicide Gene Therapy of Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0078711
- By:
- Publication type:
- Article
A New Pyrimidine-Specific Reporter Gene: A Mutated Human Deoxycytidine Kinase Suitable for PET During Treatment with Acycloguanosine-Based Cytotoxic Drugs.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 9, p. 1395, doi. 10.2967/jnumed.109.074344
- By:
- Publication type:
- Article
Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth.
- Published in:
- FASEB Journal, 2007, v. 21, n. 3, p. 754, doi. 10.1096/fj.06-6847com
- By:
- Publication type:
- Article
Targeting the relaxin hormonal pathway in prostate cancer.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 10, p. 2287, doi. 10.1002/ijc.29079
- By:
- Publication type:
- Article
Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.
- Published in:
- Transfusion, 2014, v. 54, n. 11, p. 2871, doi. 10.1111/trf.12680
- By:
- Publication type:
- Article
Cell Fate Control Gene Therapy Based on Engineered Variants of Human Deoxycytidine Kinase.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 5, p. 1002, doi. 10.1038/mt.2011.298
- By:
- Publication type:
- Article
Engineered Human tmpk/AZT As a Novel Enzyme/Prodrug Axis for Suicide Gene Therapy.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 5, p. 962, doi. 10.1038/mt.sj.6300122
- By:
- Publication type:
- Article